title: Regulation of PDE-4 cAMP phosphodiesterases by phosphatidic acid.
abstract: Phosphatidic acid (PA) has been previously shown to activate specifically some of the isoforms of type 4 cylic nucleotide phosphodiesterases (PDE-4) in an acellular system. In the present work, we have investigated the mechanism of PA-activating effect by using a recombinant PA-sensitive isoform, PDE-4D3. The enzyme was specifically activated by acidic phospholipids, but not by zwitterionic phospholipids or anionic detergents. The importance of the role of PA acidic groups in the activation process was confirmed by studying the influence of pH and ionic strength on activation. Crosslinking experiments suggested that PA might influence the ability of PDE-4D3 to form dimers. Binding studies performed with radiolabeled PA showed that PA binds to a PDE-4D3 preparation in a saturable manner. Specifically bound PA was displaced by anionic, but not by zwitterionic phospholipids. With a preparation of PDE-4B2, a PDE-4 isoform insensitive to PA activation, PA binding was only displaced by high concentrations of unlabeled PA, suggesting that high-affinity PA binding sites are only present on PDE-4D3. These data support the hypothesis that PA-activating effect depends on direct binding of the effector on specific sites carried by the PDE-4D3 protein.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale Unité 352, Laboratoire de Biochimie et Pharmacologie Institut National des Sciences Appliquées-Lyon, Villeurbanne, France.
authors.forename: M
authors.initials: M
authors.lastname: Grange
authors.forename: M
authors.initials: M
authors.lastname: Picq
authors.forename: A F
authors.initials: AF
authors.lastname: Prigent
authors.forename: M
authors.initials: M
authors.lastname: Lagarde
authors.forename: G
authors.initials: G
authors.lastname: Nemoz
mesh_terms: D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D000838:Anions; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D003902:Detergents / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D009994:Osmolar Concentration; D010712:Phosphatidic Acids / Q000378:metabolism / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D011487:Protein Conformation / Q000187:drug effects; D051381:Rats; D018411:Spodoptera / Q000235:genetics; D013379:Substrate Specificity
chemical_list: D000838:Anions; D003902:Detergents; D010712:Phosphatidic Acids; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4